Member Info for clairesmith

company with MCPA of £18M gives a total dividend of approximately £15.8 million to its share holders, this is a very very good company

small shake to big jump, company is paying out great dividends, wonder if another special one will happen mid 2021?

took me a few try's to buy and managed to get some, now this company is gearing into a very great position, get ready

still cant buy LOL, very good news for holders with this buying pressure

trying to top up, but cant buy - good signs

I always thought a reasonable MCAP for IQAI if they got wider integration to US and EU health services was in the £100m ball park, or at least an to be acquired for that a price in that region.

With a of TB other projects doing well wonder at what point he will fuel up and drive IQAI to those price regions.

Arteys Neuro AI product includes a brain oncology processing suite powered by Imaging Biometrics and a stroke detection software powered by Avicenna.AI.

https://marketplace.arterys.com/clinicalApp/neuroapp

looking through the IQAI main site and the investor site it appears they have done some updates, fresh wording etc.. would is a good indication of ramp up their end.

cant wait, watch this share fly on the back of RM and Braveheart fortunes!

Have seen that IQAI are now on the Curated Marketplace of Blackford Analysis

https://www.blackfordanalysis.com/application/imaging-biometrics

StoneChecker is just part of their wide portfolio now, and thats a great thing.

they have so many products at the highest quality and partnered with some of the best institutions that they have cemented their place into the emerging AI Medical Tech Space.

there is alot of things that can potentially drop in the next month or so.

have topped up today, and holding, very excited for the horizon

Now that TB has had a good time with RM and BRH, seems logical that we will be putting new pressure on IQAI to grow.

One great thing this company has is a strong USA base, and considering the issues with patient processing that C19 has created, they will be looking to AI as a way to improve patient (customer) turn over.

Second to this, with Biden coming into office this could mean more focus from US gov to fund medical and hospitals.

i got in at 29, and sold at a profit, but wish I had stayed around for the price it is now, absolutely flying today!

anyways, good luck all and hope everyone has a wonderful new year.

from a technology point of view its very exciting to see what this company are doing.

they have so many patents, products, and partnerships, that are constantly growing, that its amazing to see the new Medical AI tech coming to market, and how this will benefit everyone.

I'm very happy to invest just to make sure this company are be backed for the good work and better society they are contributing to.

Share for 2021 = IQAI = the new age of medical tech is here!

for this share to have those "biggish" sells happen, and the price to only go down a bit is great news, and shows great foundation.

We usually get a couple of RNS updates a month, so expect something within the next few weeks.

Company has soooo many patents, productions, partnerships, that we can easily see a multi bagger H1 2021.

GLA DYOR

the shake started in Oct, so its been a longway down, now hitting sustain level to move back up on news.

oh look what happened lol

cheap shares to be picked up by us and MM, looks like a decent sized shake, should bounce by afternoon

bigger picture, even when UK is out of lockdown does not mean that other countries will be open, so Easter to Summer time there is a high percentage change that Britons will not be able to leave the UK there a lot of money and trade going to Marstons

Long-term testing will become a norm to catch flare ups of viruses. It's quicker to develop a test than a vaccine.

Omega have scaled to meet capacity and support many countries for this new norm.